Quarterly Forecast. The Parties specifically acknowledge and agree that (as set out in Section 1 of the Traxys Black Mass Agreement) all decisions concerning Spoke operations and the timing and quantity of Black Mass available for sale shall be made by the North America Seller, in its sole and absolute discretion. Specifically, North America Seller may determine that some or all of its Black Mass production may be required for internal purposes (including inventory build, commissioning and start-up of commercial production at the Rochester Hub), thus reducing the quantity of Black Mass available for sale to third parties. At least three months prior to the start of each calendar year (i.e., by October 1, 2024 in respect of 2025), and at least [XXX] prior to the start of each quarter, beginning with the third calendar quarter of 2024 (each a “Quarterly Forecast”), North America Seller shall advise each of Traxys and Glencore of the volume and specifications of Black Mass expected to be: (a) produced, (b) required for internal purposes, and (c) available for sale to third parties, quarterly, on a rolling 12-month basis.
Quarterly Forecast. The Parties specifically acknowledge and agree that all decisions concerning Hub operations and the timing and quantity of Refined Products available for sale shall be made by the North America Seller, in its sole and absolute discretion. Li-Cycle shall keep each of Traxys and Glencore apprised of the progress of development of the Rochester Hub project with a view to providing Traxys and Glencore with information on certain Refined Products that may be available for sale during the Term (i.e., specifically, Lithium Carbonate, Graphite Concentrate and, if applicable, Nickel Sulphate, Cobalt Sulphate, and Manganese Carbonate). From and after the start of commissioning of the Rochester Hub, at least three months prior to the start of each calendar year, and at least [XXX] prior to the start of each calendar quarter, North America Seller shall advise each of Traxys and Glencore of the volume and specifications of such Refined Products expected to be: (a) produced, and (b) available for sale, quarterly, on a rolling 12-month period (or such other basis as may be agreed by the Parties).
Quarterly Forecast. On the Effective Date of this Agreement and thereafter on the first day of each calendar quarter during the Term, Distributor shall provide Xenogen with a twelve (12) month rolling forecast setting forth its estimated requirements for delivery to Distributor of Licensed Products on a monthly basis, including both its requirements based on its Minimum Sales Commitment pursuant to Section 6.3, and its good faith forecast of reasonable sales above that amount (“Quarterly Forecast”). Each Quarterly Forecast will be in English and contain content reasonably specified by Xenogen, including forecasted monthly demand for each Licensed Product (beginning with the first day of the next calendar month) and reasonable details of sales and business prospects. Such Quarterly Forecasts are for planning purposes only, and will not be binding on either Party. Notwithstanding the foregoing, Distributor will use commercially reasonable efforts to make each Quarterly Forecast as accurate as possible. In the event that Distributor believes that a Quarterly Forecast is materially inaccurate, Distributor shall promptly notify Xenogen and provide Xenogen with a revised Quarterly Forecast.
Quarterly Forecast. SNAPSHOT shall provide an estimate to Synercard of its expected sales of Software for the following quarter broken down for each product title, including but not limited to Asure ID Connect and Asure ID Server credits ("Forecast"). SNAPSHOT shall provide the Forecast to Synercard by pre-paid post or electronic mail on the fIrst day of each calendar quarter. 12.2
Quarterly Forecast. The Purchaser and/or Purchaser’s Nominated Contract Manufacturer (as applicable) shall provide the Supplier with a rolling forecast schedule of demand showing their estimated requirements for API for the following [***] months (“Forecast Schedule”). The Forecast Schedule shall be updated [***] and shall contain, in addition to quantity of API required, the requested delivery date. The first such Forecast Schedule shall be provided to the Supplier on the date hereof and thereafter by the first (1st) day of each [***]. All forecasts and orders under this Agreement shall be in multiples of the minimum order quantity of [***].
Quarterly Forecast. 1. Each Quarter of the PSA term, Client shall provide to SBL a rolling eight (8) Quarter Forecast (the “Quarterly Forecast”) at least by thirty (30) days before the end of the then-current Quarter. The first Quarterly Forecast shall be provided by March 31, 2020.
Quarterly Forecast. Starting twelve (12) months prior to the expected first launch, Modex will, before each January 1, April 1, July 1 and October 1, present to CTI a written forecast estimating the monthly quantities of Modex Licensed Products to be delivered during the next twelve (12) month period. With such forecast, Modex will provide CTI with a summary of its inventory, if any. Modex will place firm orders for delivery not less than ninety (90) days prior to the start of the calendar quarter for which shipment is ordered, and CTI will be obliged (subject to such orders being within CTI's supply capacity), to deliver all ordered quantities of Modex Licensed Product by the delivery date stated in the order, except to the extent that such delivery would exceed either of the following:
Quarterly Forecast. Distributor shall provide ZO SKIN HEALTH with reports of its activities, competitor activities, and other information regarding the Products and Related Products and the markets for them in the Territory in such detail and with such frequency as ZO SKIN HEALTH shall reasonably require from time to time. In order to help ZO SKIN HEALTH provide inventory on a timely and consistent basis to Distributor, Distributor agrees to provide to ZO SKIN HEALTH on a quarterly basis a twelve (12) month rolling forecast of Distributor’s projected purchase orders (including that of sub-distributors) on the form attached hereto as Exhibit B. Distributor's provision of the above-mentioned forecast shall not be interpreted as a commitment from Distributor to buy any Products or Related Products in excess of Distributor's Minimum Purchase Requirement, unless otherwise agreed to in writing by the Parties.
Quarterly Forecast. Lilly shall provide to ViroPharma Lilly’s forecast prior to any date in which ViroPharma is required to submit a forecast for Marketed Product to [***]. ViroPharma shall thereafter include such forecast in its forecast, subject to its requirements during the forecast period.
Quarterly Forecast. Prior to the end of each Calendar Quarter, Licensee shall provide MGI with a statement of its estimated purchase requirements (“Estimated Requirements”) and expected Delivery dates for Licensed Product for the four (4) Calendar Quarters next succeeding such Calendar Quarter (the “Forecast”). The first six (6) months of the Forecast shall constitute commitments to purchase Licensed Product. * Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
